Table 1.
Demographics and clinical characteristics of the study patients (n = 71).
| Characteristic | Mean ± SD |
|---|---|
| Age (years) | 61 ± 9 |
| Gender (male, n/%) | 51/72 |
| Type 2 diabetes (n/%) | 35/49 |
| Dyslipidemia (n/%) | 55.0/77 |
| Hyperuricemia (n/%) | 43.0/61 |
| Smokers (n/%) | 8.0/11 |
| Ischemic cardiopathy (n/%) | 8.0/11 |
| Peripheral arteriopathy (n/%) | 9.0/13 |
| Cardiovascular events (n/%) | 12.0/17 |
| Hypertension (n/%) | 71.0/100 |
| ACEI (n/%) | 7.0/10 |
| ARB (n/%) | 61.0/86 |
| Diuretics (n/%) | 41.0/58 |
| CCB (D) (n/%) | 45.0/63 |
| Beta-blocker (n/%) | 28.0/39 |
| Central Alfa-Blocker (n/%) | 31.0 /44 |
| Other antihypertensive drugs (n/%) | 4.0/6 |
| Body weight (kg) | 90.6 ± 13.0 |
| Body mass index (kg/m2) | 32.0 ± 4.0 |
| Waist circumference (cm) in men | 110.3 ± 10.1 |
| Waist circumference (cm) in women | 108.0 ± 10.1 |
| Systolic blood pressure (mmHg) | 136.3 ± 25.5 |
| Diastolic blood pressure (mmHg) | 84.1 ± 16.6 |
| Mean blood pressure (mmHg) | 108.4 ± 19.0 |
| Heart rate (bpm) | 64.0 ± 13.3 |
Quantitative and qualitative variables are presented as mean ± standard deviation and number/percentage, respectively. ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB (D): calcium channels blocker dihydropyridine.